ClinConnect ClinConnect Logo
Search / Trial NCT06523842

Cross Culture Adaptation Validity and Reliability of Arabic Version of Cornell Muscloskeletal Discomfort Questionnaire

Launched by SARA MORTADA MOHAMED · Jul 23, 2024

Trial Information

Current as of November 11, 2025

Enrolling by invitation

Keywords

Arabic Version Of Cornell Muscloskeletal Questionnaire Validity And Reliability

ClinConnect Summary

This study is about translating and testing an Arabic version of the Cornell Musculoskeletal Discomfort Questionnaire (CMDQ), a short survey that asks adults about aches, pains, or discomfort in different parts of the body over the past week. The goal is to see if the Arabic version is easy to understand and reliable for research purposes. This is observational work (no medical treatment) and researchers will check how well the questionnaire works before using it more broadly.

Anyone 18–60 years old who speaks Arabic and can read and fill out forms is invited if they work in a sedentary office job or in standing work. Both men and women can participate. Exclusions include cognitive problems or any condition that would make filling out the survey difficult, plus some medical conditions like inflammatory rheumatic diseases, neurological or psychiatric disorders. About 540 people are planned to take part, and the study is being run at Cairo University in Egypt. Participants will complete a 54-item questionnaire, which takes about 15 minutes. Results aren’t available yet; the study aims to confirm that the Arabic CMDQ is valid and reliable for measuring musculoskeletal discomfort.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - Male and female
  • Being sedentary office workers
  • Being standing workers .Being literate and speaking Arabic. .Patients were aged from 18 to 60 years old.
  • Exclusion Criteria:
  • Inability to complete the form due to cognitive impairment. .Individuals who were unable or unwilling to complete study outcomes or provide informed consent.
  • Systematic inflammatory rheumatic diseases .Neurological conditions. .Psychiatric disorders.

About Sara Mortada Mohamed

Sara Mortada Mohamed is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a background in healthcare and a focus on innovative therapeutic solutions, she leads initiatives that prioritize rigorous study design, ethical standards, and regulatory compliance. Her strategic approach fosters collaboration among multidisciplinary teams, ensuring the efficient execution of clinical trials while maintaining the highest quality of data integrity and participant safety. Through her leadership, she aims to contribute to the development of groundbreaking treatments that address unmet medical needs.

Locations

Dokki, Giza, Egypt

Patients applied

0 patients applied

Trial Officials

haitham El Hafez, prof

Study Director

cairo university ,egypt

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported